These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 17095175

  • 21. Evaluation of several fluoroquinolones and beta-lactams in terms of their capability to restrict the selection of fluoroquinolone-resistant Salmonella: in vitro models.
    Cebríán L, Rodríguez JC, Escribiano I, Royo SG.
    APMIS; 2007 Dec; 115(12):1376-82. PubMed ID: 18184408
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae.
    Allen GP, Hankins CD.
    J Antimicrob Chemother; 2009 Aug; 64(2):359-63. PubMed ID: 19460783
    [Abstract] [Full Text] [Related]

  • 23. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C, de Jong A, Friederichs S, Cloeckaert A, Schwarz S.
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [Abstract] [Full Text] [Related]

  • 24. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
    Zheng J, Cui S, Meng J.
    J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
    [Abstract] [Full Text] [Related]

  • 25. Stability of fluoroquinolone resistance in Streptococcus pneumoniae clinical isolates and laboratory-derived mutants.
    Smith-Adam HJ, Nichol KA, Hoban DJ, Zhanel GG.
    Antimicrob Agents Chemother; 2005 Feb; 49(2):846-8. PubMed ID: 15673786
    [Abstract] [Full Text] [Related]

  • 26. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
    Fuller JD, Low DE.
    Clin Infect Dis; 2005 Jul 01; 41(1):118-21. PubMed ID: 15937772
    [Abstract] [Full Text] [Related]

  • 27. Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy.
    Croisier D, Etienne M, Bergoin E, Charles PE, Lequeu C, Piroth L, Portier H, Chavanet P.
    Antimicrob Agents Chemother; 2004 May 01; 48(5):1699-707. PubMed ID: 15105123
    [Abstract] [Full Text] [Related]

  • 28. Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila.
    Almahmoud I, Kay E, Schneider D, Maurin M.
    J Antimicrob Chemother; 2009 Aug 01; 64(2):284-93. PubMed ID: 19474069
    [Abstract] [Full Text] [Related]

  • 29. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN, Sader HS, Stilwell MG, Fritsche TR.
    Diagn Microbiol Infect Dis; 2007 May 01; 58(1):1-7. PubMed ID: 17408904
    [Abstract] [Full Text] [Related]

  • 30. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
    Morrissey I, Colclough A, Northwood J.
    Int J Antimicrob Agents; 2007 Oct 01; 30(4):345-51. PubMed ID: 17643269
    [Abstract] [Full Text] [Related]

  • 31. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
    Beeton ML, Chalker VJ, Kotecha S, Spiller OB.
    J Antimicrob Chemother; 2009 Sep 01; 64(3):529-38. PubMed ID: 19567408
    [Abstract] [Full Text] [Related]

  • 32. Frequency of 1st- and 2nd-step topoisomerase mutations in Streptococcus pneumoniae following levofloxacin and moxifloxacin exposure.
    Hovde LB, Simonson DA, Rotschafer JC.
    Diagn Microbiol Infect Dis; 2008 Mar 01; 60(3):295-9. PubMed ID: 18053674
    [Abstract] [Full Text] [Related]

  • 33. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
    Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier JC, Megraud F, Soussy CJ, Cambau E.
    Int J Antimicrob Agents; 2007 Apr 01; 29(4):389-96. PubMed ID: 17303392
    [Abstract] [Full Text] [Related]

  • 34. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
    Jones RN, Fritsche TR, Sader HS, Stilwell MG.
    Diagn Microbiol Infect Dis; 2007 May 01; 58(1):9-17. PubMed ID: 17408903
    [Abstract] [Full Text] [Related]

  • 35. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens.
    Li Q, Bi X, Diao Y, Deng X.
    Am J Vet Res; 2007 Aug 01; 68(8):812-5. PubMed ID: 17669019
    [Abstract] [Full Text] [Related]

  • 36. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
    Rodríguez-Cerrato V, García P, Del Prado G, García E, Gracia M, Huelves L, Ponte C, López R, Soriano F.
    J Antimicrob Chemother; 2007 Nov 01; 60(5):1159-62. PubMed ID: 17827138
    [Abstract] [Full Text] [Related]

  • 37. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
    Preisler A, Heisig P.
    J Antimicrob Chemother; 2009 Feb 01; 63(2):290-4. PubMed ID: 19033246
    [Abstract] [Full Text] [Related]

  • 38. Experimental study of clinafloxacin alone and in combination in the treatment of ciprofloxacin-susceptible and -resistant pneumococcal meningitis.
    Domenech A, Cabellos C, Ribes S, Tubau F, Viladrich PF, Liñares J, Gudiol F.
    Microb Drug Resist; 2003 Feb 01; 9 Suppl 1():S53-9. PubMed ID: 14633368
    [Abstract] [Full Text] [Related]

  • 39. Antipneumococcal activity of ertapenem compared with gatifloxacin in a temperature-sensitive murine model of acute pneumonia.
    De Azavedo JC, Dresser L, Duncan CL, Walker SE, Low DE, Bast DJ.
    J Chemother; 2007 Aug 01; 19(4):392-7. PubMed ID: 17855183
    [Abstract] [Full Text] [Related]

  • 40. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.
    Ip M, Chau SS, Chi F, Cheuk ES, Ma H, Lai RW, Chan PK.
    Antimicrob Agents Chemother; 2007 Jun 01; 51(6):2192-4. PubMed ID: 17371818
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.